BeiGene, Ltd.
BTK inhibitors with improved dual selectivity

Last updated:

Abstract:

Disclosed herein is a tri-substituted phenyl Btk inhibitors with improved dual selectivity, a method and a composition for inhibiting Btk and treating disease associated with undesirable Btk activity (Btk-related diseases).

Status:
Grant
Type:

Utility

Filling date:

12 Aug 2018

Issue date:

5 Jul 2022